Rleenaerts2023-07-24T00:19:21+00:00MA 2024 Plans VBC Providers Cheer 3 Year Risk Model Phase-InRleenaerts2023-07-24T00:19:21+00:0004/02/2023|
Rleenaerts2023-07-24T00:18:34+00:00Medicare Advantage FAQRleenaerts2023-07-24T00:18:34+00:0003/28/2023|
Team2023-12-12T22:10:14+00:00Industry Excoriates MA 2024 Rate NoticeTeam2023-12-12T22:10:14+00:0002/28/2023|
capitolstreet2023-08-03T18:16:12+00:00Gene Therapy Legislation Codifies Best Price(s)capitolstreet2023-08-03T18:16:12+00:0002/25/2023|
capitolstreet2023-08-07T02:09:14+00:00CBO: Window Into IRA Rx Price Assumptionscapitolstreet2023-08-07T02:09:14+00:0002/21/2023|
capitolstreet2023-02-17T16:48:00+00:00PBM Transparency Act Likely to Pass Senate Committeecapitolstreet2023-02-17T16:48:00+00:0002/17/2023|
capitolstreet2023-08-07T02:08:22+00:00ARPA-H & FDA Life Sciences Outlook Brightcapitolstreet2023-08-07T02:08:22+00:0002/15/2023|
capitolstreet2023-08-07T02:06:55+00:003 Drug Pilots: Cell & Gene in Medicaid, $2Medicare Generics & Accelerated Approval Paycapitolstreet2023-08-07T02:06:55+00:0002/14/2023|
capitolstreet2023-02-08T16:29:00+00:00Biden’s Second State of the Unioncapitolstreet2023-02-08T16:29:00+00:0002/08/2023|
capitolstreet2023-12-12T21:45:56+00:002024 MA Rates Proposed -2.27%capitolstreet2023-12-12T21:45:56+00:0002/01/2023|
capitolstreet2023-08-07T02:04:07+00:00Medicaid Unwind Starts Feb 1, 2023capitolstreet2023-08-07T02:04:07+00:0001/31/2023|
capitolstreet2023-01-30T17:37:00+00:00RADV: Manageable for MA Plans, VBC Providerscapitolstreet2023-01-30T17:37:00+00:0001/30/2023|
